Search Results

Displaying Results 1-1 of 1 "'TCRT'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Valion Bio Appoints Melinda Lackey as General Counsel

May 04, 2026, 16:05 ET Valion Bio Appoints Melinda Lackey as General Counsel

Ms. Lackey joins from Alaunos Therapeutics (Nasdaq: TCRT), a clinical trial-stage oncology cell therapy company, where she served as Senior Vice President of Legal & Administration. In that role, she managed

More news about: Valion Bio, Inc.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.